HSPA5 and lung cancer: As shown in Figure 5A, the expression levels of GRP78, p‐PERK, IRE1, ATF6, ATF4 and p‐eIF2α were increased in all three human lung cancer cells in a dose‐dependent manner (Figure 5A).